Talk:Agomelatine

From Wikipedia, the free encyclopedia

	Agomelatine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Stub	This article has been rated as stub-Class on the quality scale.

On 27 July 2006 the Committe for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMEA) recommended a refusal of the marketing authorisation of Valdoxan/Thymanax. The major concern was that efficacy had not been sufficiently shown. The CHMP had no special concerns about the side effects. See <http://www.emea.eu.int/pdfs/human/opinion/267703062en.pdf>.

Added previous comment on the main article because it states very important informations about this drug. Artkin 08:54, 2 April 2007 (UTC)

[edit] Acid antidote

ppl who use acid could use this to stop tripping and sleep properly —Preceding unsigned comment added by 202.161.0.84 (talk) 10:18, 9 November 2007 (UTC)